目的　观察经肝动脉注入硬化剂治疗肝海绵状血管瘤的临床效果及长期疗效 ,了解该治疗方法的优缺点。方法　对 3 2例肝海绵状血管瘤患者行经肝动脉注入硬化剂治疗 ,术后观察其临床效果及长期疗效。结果　 3 2例患者采用经肝动脉注入硬化剂治疗后 ,瘤体全部明显缩小 ,为硬化剂所填充 ,且无明显副作用及并发症。结论　经肝动脉注入硬化剂治疗肝海绵状血管瘤是一种安全、创伤小、长期疗效好的治疗方法 Objective To observe the clinical effects and long-term efficacy of hepatic cavernous hemangiomas treated by hepatic artery injection of sclerosant to understand the advantages and disadvantages of this treatment. Methods Forty-two patients with hepatic cavernous hemangioma were treated with hepatic artery injection of sclerotherapy, and the clinical effect and long-term efficacy were observed after operation. Results 32 cases of patients treated with hepatic artery injection of sclerotherapy, the tumor was significantly reduced, filled with sclerosing agents, and no significant side effects and complications. Conclusion The treatment of hepatic cavernous hemangiomas by hepatic artery injection of sclerotherapy is a safe, less traumatic and long-term curative effect